| Ms Audrey E Zimmerman, | |
|
1501 Lehigh St, Suite 201, Allentown, PA 18103-3880 | |
| (610) 289-0114 | |
| (610) 289-4282 |
| Full Name | Ms Audrey E Zimmerman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1501 Lehigh St, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720114697 | NPI | - | NPPES |
| 01698424 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL-003608-L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Audrey E Zimmerman, 1501 Lehigh St, Suite 201, Allentown, PA 18103-3880 Ph: (610) 289-0114 | Ms Audrey E Zimmerman, 1501 Lehigh St, Suite 201, Allentown, PA 18103-3880 Ph: (610) 289-0114 |
News Archive
Prescription opioid headlines are staggering: 40 Americans die each day from overdoses involving prescription opioids; they cost the United States economy $78.5 billion a year; and 227 million opioid prescriptions were handed out in the U.S. in 2015.
The world has been brought to a stand-still by the COVID-19 pandemic that has affected 197 countries, areas and territories, infected 467,594, and killed 21,181 individuals as of today. COVID-19 disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a single-stranded RNA virus, contagious in humans.
HIV infected children in South Africa who were exposed to the drug nevirapine at birth (used to help prevent mother to child HIV transmission) and then received a protease inhibitor (PI) for viral suppression achieved lower rates of viremia (virus in the blood stream) if they were switched to nevirapine, compared to children who continued on the PI-based regimen, according to a study in the September 8 issue of JAMA.
In my view, one of the greatest changes in recent history that has come about in nuclear medicine production is Australia's full adoption of Low-Enriched Uranium (LEU) technologies – in both the fuel and the target plates.
Abbott and Bristol-Myers Squibb Company today announced interim results from the Phase 2 portion of a Phase 1b/2 open-label study which showed a high objective response rate (ORR) among patients with relapsed multiple myeloma who received elotuzumab plus lenalidomide and low-dose dexamethasone.
› Verified 3 days ago
Adrienne Westheim, M.S, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 930 Springhouse Rd, Allentown, PA 18104 Phone: 610-390-5014 Fax: 610-398-7134 | |
Bailey Mckeon, M.A, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1925 W Turner St, Allentown, PA 18104 Phone: 610-794-5264 | |
Sarah Wanuga, MS, CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 850 S 5th St, Allentown, PA 18103 Phone: 610-776-3578 | |
Megan Pellek, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 S Cedarbrook Rd, Allentown, PA 18104 Phone: 610-395-3727 Fax: 610-395-7919 | |
Cailee Carmella, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4136 W Tilghman St Apt 5, Allentown, PA 18104 Phone: 484-822-6040 | |
Ellen Susan Krajcir, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 850 S 5th St, Allentown, PA 18103 Phone: 610-776-3578 | |
Tiffany Ferreira, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 888-402-5846 |